News

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
ConsumerAffairs1d
23andMe founder saves company with last-minute $305 million bid
DNA data saved: 23andMe co-founder Anne Wojcicki has bid $305 million through a nonprofit to acquire her bankrupt company, ...
Information Age1d
‘Thrilled’ 23andMe founder buys firm out of bankruptcy
The DNA data of more than 15 million customers of DNA testing firm 23andMe is set to be returned to the control of 23andMe co ...
GOP lawmaker grills ex-CEO over 23andMe pronouns post, forcing her to admit she doesn’t know what they mean
Rep. Gill grilled 23andMe's co-founder Anne Wojcicki during a House hearing where she revealed that she did not understand ...